TGF-β1, a multifunctional key biomediator, is highly expressed in RA synovial tissue and affects alterations in the 28-joint disease activity score and erythrocyte sedimentation rate (ESR) in RA patients (45). The gene discussed is TGFB1; the disease is rheumatoid arthritis.